118 related articles for article (PubMed ID: 7015425)
21. Randomized controlled study of chemoimmunotherapy with bestatin of acute nonlymphocytic leukemia in adults.
Ota K; Ogawa N
Biomed Pharmacother; 1990; 44(2):93-101. PubMed ID: 2224060
[TBL] [Abstract][Full Text] [Related]
22. [Randomized controlled trial of postoperative adjuvant chemotherapy with bestatin for gastric cancer].
Tanaka T; Oka T; Hashimoto I
Gan To Kagaku Ryoho; 1985 Jan; 12(1):125-33. PubMed ID: 3917653
[TBL] [Abstract][Full Text] [Related]
23. Immunological and haematological monitoring in bladder cancer patients receiving adjuvant bestatin treatment following radiation therapy. A prospective randomized trial.
Blomgren H; Edsmyr F; Esposti PL; Näslund I
Biomed Pharmacother; 1984; 38(3):143-9. PubMed ID: 6383491
[TBL] [Abstract][Full Text] [Related]
24. A review of clinical studies on bestatin, 1976--1978.
Oka S
Recent Results Cancer Res; 1981; 76():222-31. PubMed ID: 7015429
[No Abstract] [Full Text] [Related]
25. [Effect of bestatin on primary tumor and prognosis in patient with esophageal carcinoma].
Sato H; Isono K; Nabeya K; Arai Y; Endo M; Ide H; Mitomi T; Makuuchi H; Taguchi G
Nihon Gan Chiryo Gakkai Shi; 1984 Dec; 19(10):2312-26. PubMed ID: 6533209
[No Abstract] [Full Text] [Related]
26. [Clinical evaluation of bestatin (NK-421) supplementing radiotherapy in the treatment of lung cancer].
Hamada F; Imajo Y; Inomata Y; Ichiyanagi A; Ashida C; Gose K; Imanaka K; Takada Y; Kimura S; Ogawa Y
Nihon Gan Chiryo Gakkai Shi; 1983 Aug; 18(5):1175-80. PubMed ID: 6663170
[No Abstract] [Full Text] [Related]
27. Combination therapy with bestatin in inoperable lung cancer. A randomized trial.
Takada M; Fukuoka M; Negoro S; Kusunoki Y; Matsui K; Masuda N; Sakai N; Ryu S; Takifuji N; Kudo S
Acta Oncol; 1990; 29(6):821-5. PubMed ID: 2223156
[TBL] [Abstract][Full Text] [Related]
28. Bestatin therapy of patients with atopic dermatitis.
Thestrup-Pedersen K; Cramers M; Kongsholm H; Zachariae H
Acta Derm Venereol; 1983; 63(6):549-52. PubMed ID: 6198850
[TBL] [Abstract][Full Text] [Related]
29. Randomized double-blind placebo-controlled trial of bestatin in patients with resected stage I squamous-cell lung carcinoma.
Ichinose Y; Genka K; Koike T; Kato H; Watanabe Y; Mori T; Iioka S; Sakuma A; Ohta M;
J Natl Cancer Inst; 2003 Apr; 95(8):605-10. PubMed ID: 12697853
[TBL] [Abstract][Full Text] [Related]
30. Partial review of immunotherapeutic pharmacology in stem cell transplantation.
Bierman PJ; Abe F; Buyukberber S; Ino K; Talmadge JE
In Vivo; 2000; 14(1):221-36. PubMed ID: 10757081
[TBL] [Abstract][Full Text] [Related]
31. Three new agents for immunotherapy trials: azimexon, bestatin, and tuftsin.
Mathé G; Florentin I; Bruley-Rosset M; Goutner A; Serrou B
Recent Results Cancer Res; 1982; 80():331-3. PubMed ID: 6977171
[No Abstract] [Full Text] [Related]
32. [Study on the antitumor effect of an inhibitor against cell surface enzyme (Bestatin)].
Sonoyama T; Terata N; Matsumoto H; Nozaki A; Kimura K; Kurioka H; Hashimoto I; Tsunoda F; Kodama M
Nihon Gan Chiryo Gakkai Shi; 1982 Aug; 17(5):1264-9. PubMed ID: 6984058
[No Abstract] [Full Text] [Related]
33. Bestatin in resected lung cancer. A randomized clinical trial.
Yasumitsu T; Ohshima S; Nakano N; Kotake Y; Tominaga S
Acta Oncol; 1990; 29(6):827-31. PubMed ID: 2223157
[TBL] [Abstract][Full Text] [Related]
34. Clinical trials of bestatin for leukemia and solid tumors.
Ota K; Uzuka Y
Biotherapy; 1992; 4(3):205-14. PubMed ID: 1599804
[TBL] [Abstract][Full Text] [Related]
35. Prospective randomized controlled study on bestatin in resectable gastric cancer.
Niimoto M; Hattori T
Biomed Pharmacother; 1991; 45(2-3):121-4. PubMed ID: 1912368
[TBL] [Abstract][Full Text] [Related]
36. [Postoperative adjuvant immunochemotherapy with bestatin for stomach cancer. Randomized controlled trial: first report].
Yoshinaka K; Nakano A; Toge T; Niimoto M; Hattori T
Gan To Kagaku Ryoho; 1985 Jul; 12(7):1458-64. PubMed ID: 3925887
[TBL] [Abstract][Full Text] [Related]
37. [Antitumor effect of bestatin combined with bleomycin against hepatoma AH 66 subcutaneously transplanted in rats].
Abe F; Yamashita T; Takahashi K; Matsuda A; Ichikawa T; Umezawa H
Jpn J Antibiot; 1984 Apr; 37(4):589-92. PubMed ID: 6206250
[TBL] [Abstract][Full Text] [Related]
38. Changes of the blood lymphocyte population in cancer patients treated with bestatin, a new immunomodulator. A phase I study.
Blomgren H; Strender LE; Edsmyr F
Biomedicine; 1980 Dec; 32(4):178-85. PubMed ID: 7470579
[TBL] [Abstract][Full Text] [Related]
39. Do tuftsin and bestatin constitute a biopharmacological immunoregulatory system?
Mathé G
Cancer Detect Prev Suppl; 1987; 1():445-55. PubMed ID: 3319151
[TBL] [Abstract][Full Text] [Related]
40. Enhancement of antitumor effect of cytotoxic agents by bestatin.
Abe F; Shibuya K; Ashizawa J; Takahashi K; Horinishi H; Matsuda A; Ishizuka M; Takeuchi T; Umezawa H
J Antibiot (Tokyo); 1985 Mar; 38(3):411-4. PubMed ID: 3924871
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
